Post by Luminary Group

As of April 30, 2026, Paul Hitchin will step down from his role as Chief Financial Officer, following a period where he helped guide the business through significant financial and strategic transformation. From May 1, 2026, Claire Hinshelwood will step into the CFO role, bringing 30+ years of global financial leadership experience, including senior roles at BMI Group, Novartis, and Syngenta. This transition comes at a pivotal time as Evotec continues to evolve its business model, scale innovation, and drive toward sustainable, profitable growth. From a market perspective, this highlights a few key themes we continue to see across Life Sciences: -The increasing importance of CFOs as strategic transformation leaders, not just financial stewards -The value of cross-industry leadership experience in navigating complex operating environments -The critical role of finance leadership in scaling innovation-driven organisations We’ll be watching closely as Claire partners with Christian Wojczewski and the wider leadership team to shape the next phase of growth. #LifeSciences #Leadership #CFO #ExecutiveSearch #Biotech #Transformation https://lnkd.in/eKSmfSdR